• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

ECMO-facilitated resuscitation may improve survival compared to ACLS in patients with out-of-hospital cardiac arrests

byNeel MistryandTeddy Guo
December 18, 2020
in Cardiology, Chronic Disease, Emergency
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Survival to hospital discharge was higher among patients in the ECMO-facilitated resuscitation group versus those receiving ACLS resuscitation.

2. Patients who received early ECMO had significantly higher survival at 3 and 6 months compared to the ACLS group.

Evidence Rating Level: 2 (Good)

Study Rundown: Out-of-hospital cardiac arrest (OHCA) accounts for a large number of cardiac mortalities in North America. Among patients with OHCA and ventricular fibrillation, nearly half present with refractory ventricular fibrillation that is unresponsive to advanced cardiac life support (ACLS). This single centre, open-label, randomized controlled trial aimed to compare survival to hospital discharge between patients treated with ACLS and extracorporeal membrane oxygenation (ECMO)-facilitated resuscitation. Primary outcome for this study was survival to hospital discharge, while secondary endpoints included cumulative survival and functionally favourable status at hospital discharge, and at 3 and 6 months after discharge.

Study results demonstrated a significant increase in survival to discharge among patients in the ECMO group compared to the ACLS group. In addition, cumulative survival was significantly better with early ECMO than with standard ACLS treatment. However, many patients in the early ECMO group reported hospitalization-related reduced functional assessment at discharge. This randomized controlled trial was limited by a small sample size since only 29 patients – all from a single medical centre – were included in the analysis. Nonetheless, this study is the first to show that ECMO-facilitated resuscitation improves survival in patients presenting with OHCA and refractory ventricular fibrillation versus standard ACLS.

Click to read the study in The Lancet

Relevant Reading: Extracorporeal Cardiopulmonary Resuscitation (ECPR) for Out-of-Hospital Cardiac Arrest due to Pulseless Ventricular Tachycardia/Fibrillation

RELATED REPORTS

The SEPSISPAM trial: Mean arterial pressure targets in septic shock [Classics Series]

2 Minute Medicine Rewind June 13, 2022 

2 Minute Medicine Rewind June 6, 2022

In-depth [randomized controlled trial]: Between Aug 8, 2019, and Jun 14, 2020, 36 patients were assessed for eligibility at the University of Minnesota Medical Center (USA). Included patients were those between 18-75 years of age with OHCA and refractory ventricular fibrillation, no return of spontaneous circulation (ROSC) after three shocks, automated cardiopulmonary resuscitation, and estimated transfer time to catheterization laboratory <30 minutes. Patients with initial pulseless electrical activity (PEA), transfer time > 30 minutes, and ROSC with second shock were excluded. Altogether, 30 patients were enrolled in the study and 29 patients (14 in the ECMO group and 15 in the ACLS group) were included in the analysis. Baselines characteristics were similar between the study groups.

Among enrolled patients, the mean age was 59 years (standard deviation [SD] 10, range 36-73) and 83% were male. The primary outcome of survival to hospital discharge was observed among 6 patients (43%, 95% credible interval 21.3-67.7) in the early ECMO group compared to 1 patient (7%, 95% CI 1.6-30.2) in the standard ACLS group (risk difference 36%, 95% credible interval 3.7-59.2, posterior probability of ECMO superiority 0.9861). Survival at 3 and 6 months was significantly improved in the early ECMO group (6 out of 14 patients at 3 and 6 months) compared to that in the standard ACLS group (none at 3 and 6 months, p=0.0063). The secondary outcome of cumulative survival was significantly better with early ECMO than with standard ACLS treatment (hazard ratio [HR] 0.16, 95% confidence interval [CI] 0.06-0.41, log-rank test p<0.0001). In the early ECMO group, 2 patients met the resuscitation discontinuation criteria and died prior to treatment whereas 13 patients in the standard ACLS group died due to unsuccessful resuscitation. Findings from this study suggest that early ECMO-facilitated resuscitation significantly improved survival to hospital discharge for patients with OHCA and refractory ventricular fibrillation compared to standard ACLS resuscitation.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ACLSadvanced cardiac life support (ACLS)cardiac arrestcardiologyextracorporeal membrane oxygenation (ECMO)resuscitation
Previous Post

#VisualAbstract Melphalan 200mg/m2 Versus Reduced Doses of Melphalan in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation

Next Post

Seasonal malaria chemoprevention program shows cost-effective prevention for children in Africa

RelatedReports

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Cardiology Classics

The SEPSISPAM trial: Mean arterial pressure targets in septic shock [Classics Series]

June 17, 2022
Long-term outcomes for off-pump and on-pump CABG are similar
Weekly Rewinds

2 Minute Medicine Rewind June 13, 2022 

June 20, 2022
Weekly Rewinds

2 Minute Medicine Rewind June 6, 2022

June 6, 2022
Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis
Weekly Rewinds

2 Minute Medicine Rewind May 30, 2022

May 30, 2022
Next Post
RTS,SA/S01 anti-malarial vaccine efficacy wanes significantly over time

Seasonal malaria chemoprevention program shows cost-effective prevention for children in Africa

Medical vaccine exemptions increase after elimination of nonmedical exemptions

Special Rewind: COVID-19 Vaccine Edition. December 21, 2020

Influenza vaccine not associated with increased risk of epilepsy in children

Special Report: Vaccines in Development Part 1: Pfizer/BioNTech vaccine first to receive emergency use authorization

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.